207 related articles for article (PubMed ID: 19693476)
1. The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies.
Faustman DL; Davis M
J Mol Med (Berl); 2009 Dec; 87(12):1173-8. PubMed ID: 19693476
[TBL] [Abstract][Full Text] [Related]
2. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
[TBL] [Abstract][Full Text] [Related]
3. Perforin facilitates beta cell killing and regulates autoreactive CD8+ T-cell responses to antigen in mouse models of type 1 diabetes.
Trivedi P; Graham KL; Krishnamurthy B; Fynch S; Slattery RM; Kay TW; Thomas HE
Immunol Cell Biol; 2016 Apr; 94(4):334-41. PubMed ID: 26446877
[TBL] [Abstract][Full Text] [Related]
4. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
5. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
[TBL] [Abstract][Full Text] [Related]
6. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
[TBL] [Abstract][Full Text] [Related]
7. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
8. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.
Mukhopadhaya A; Hanafusa T; Jarchum I; Chen YG; Iwai Y; Serreze DV; Steinman RM; Tarbell KV; DiLorenzo TP
Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6374-9. PubMed ID: 18430797
[TBL] [Abstract][Full Text] [Related]
9. beta-Cells step up in controlling the autoimmune response.
Fiorina P
Diabetes; 2010 Aug; 59(8):1861-4. PubMed ID: 20668291
[No Abstract] [Full Text] [Related]
10. Beta-cell autoimmunity.
Fuchs YF; Adler K; Bonifacio E
Methods Mol Biol; 2012; 933():265-74. PubMed ID: 22893413
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
[TBL] [Abstract][Full Text] [Related]
12. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.
Yeo L; Woodwyk A; Sood S; Lorenc A; Eichmann M; Pujol-Autonell I; Melchiotti R; Skowera A; Fidanis E; Dolton GM; Tungatt K; Sewell AK; Heck S; Saxena A; Beam CA; Peakman M
J Clin Invest; 2018 Aug; 128(8):3460-3474. PubMed ID: 29851415
[TBL] [Abstract][Full Text] [Related]
13. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
14. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
DiLorenzo TP; Serreze DV
Immunol Rev; 2005 Apr; 204():250-63. PubMed ID: 15790363
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T cells in type 1 diabetes.
Tsai S; Shameli A; Santamaria P
Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
[TBL] [Abstract][Full Text] [Related]
16. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Serreze DV; Niens M; Kulik J; DiLorenzo TP
Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
[TBL] [Abstract][Full Text] [Related]
17. Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.
Yu C; Burns JC; Robinson WH; Utz PJ; Ho PP; Steinman L; Frey AB
J Diabetes Res; 2016; 2016():9083103. PubMed ID: 27069933
[TBL] [Abstract][Full Text] [Related]
18. Apportioning Blame: Autoreactive CD4
Varela-Calvino R; Calviño-Sampedro C; Gómez-Touriño I; Cordero OJ
Arch Immunol Ther Exp (Warsz); 2017 Aug; 65(4):275-284. PubMed ID: 28083620
[TBL] [Abstract][Full Text] [Related]
19. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
20. T-cell epitopes in type 1 diabetes.
Panagiotopoulos C; Trudeau JD; Tan R
Curr Diab Rep; 2004 Apr; 4(2):87-94. PubMed ID: 15035967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
